The latest closing stock price for Bicara Therapeutics as of May 23, 2025 is 9.27.
An investor who bought $1,000 worth of Bicara Therapeutics stock at the IPO in 2024 would have $-485 today, roughly 0 times their original investment - a -48.50% compound annual growth rate over 1 years.
The all-time high Bicara Therapeutics stock closing price was 27.07 on September 17, 2024.
The Bicara Therapeutics 52-week high stock price is 28.09, which is 203% above the current share price.
The Bicara Therapeutics 52-week low stock price is 7.80, which is 15.9% below the current share price.
The average Bicara Therapeutics stock price for the last 52 weeks is 16.84.
An investor who bought $1,000 worth of Bicara Therapeutics stock at the IPO in 2024 would have $-485 today, roughly 0 times their original investment - a -48.50% compound annual growth rate over 1 years.
The all-time high Bicara Therapeutics stock closing price was 27.07 on September 17, 2024.
The Bicara Therapeutics 52-week high stock price is 28.09, which is 203% above the current share price.
The Bicara Therapeutics 52-week low stock price is 7.80, which is 15.9% below the current share price.
The average Bicara Therapeutics stock price for the last 52 weeks is 16.84.